- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in targeted therapy for glioblastoma
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 15, Issue 8, Pages 935-946
Publisher
Informa UK Limited
Online
2015-06-29
DOI
10.1586/14737175.2015.1061934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
- (2015) M. Weller et al. CLINICAL CANCER RESEARCH
- Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression
- (2014) Günter Eisele et al. JOURNAL OF NEURO-ONCOLOGY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overcoming resistance to rapalogs in gliomas by combinatory therapies
- (2013) Michal Grzmil et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
- (2013) Maria Teresa Solomón et al. BMC CANCER
- Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma
- (2013) Panagiotis J. Vlachostergios et al. CELL BIOLOGY AND TOXICOLOGY
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma
- (2013) D. A. Reardon et al. CLINICAL CANCER RESEARCH
- The role of Gliadel wafers in the treatment of high-grade gliomas
- (2013) Amade Bregy et al. Expert Review of Anticancer Therapy
- Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
- (2013) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- “One week on–one week off”: efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center
- (2013) Norbert Galldiks et al. JOURNAL OF NEURO-ONCOLOGY
- A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas
- (2013) Vasilios Karavasilis et al. JOURNAL OF NEUROLOGY
- NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme
- (2013) David M. Peereboom et al. NEURO-ONCOLOGY
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma
- (2013) M. Balducci et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
- (2013) Emil Lou et al. Cancer Medicine
- Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
- (2012) Karl H. Plate et al. ACTA NEUROPATHOLOGICA
- A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)
- (2012) L. Burt Nabors et al. CANCER
- Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma
- (2012) David A. Reardon et al. CANCER
- Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
- (2012) David A. Reardon et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Glioblastoma cancer stem cells – From concept to clinical application
- (2012) Barbara E. Stopschinski et al. CANCER LETTERS
- Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2012) Krishna Reddy et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-inducible factor-1 as a therapeutic target in cancer
- (2012) Ceen-Ming Tang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A phase I/II trial of vandetanib for patients with recurrent malignant glioma
- (2012) T. N. Kreisl et al. NEURO-ONCOLOGY
- The Role of BCNU Polymer Wafers (Gliadel) in the Treatment of Malignant Glioma
- (2012) Seema Nagpal NEUROSURGERY CLINICS OF NORTH AMERICA
- Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma
- (2012) B. D. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant Gliomas
- (2012) Xin Hui Derryn Chan et al. Cell Reports
- Phase II Study of Short-Course Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Elderly Patients With Glioblastoma
- (2011) Giuseppe Minniti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study
- (2011) John F. de Groot et al. JOURNAL OF CLINICAL ONCOLOGY
- Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
- (2011) Mark R. Gilbert et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
- (2011) J. Drappatz et al. JOURNAL OF NEURO-ONCOLOGY
- Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib--A Phase II Trial
- (2011) M. E. Hegi et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2011) Ilya Ulasov et al. MOLECULAR MEDICINE
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- (2011) B. B. Friday et al. NEURO-ONCOLOGY
- Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma
- (2011) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
- (2011) Fabio M. Iwamoto et al. NEURO-ONCOLOGY
- MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251
- (2010) Shihai Luan et al. ARCHIVES OF MEDICAL RESEARCH
- Potential therapeutic implications of cancer stem cells in glioblastoma
- (2010) Lin Cheng et al. BIOCHEMICAL PHARMACOLOGY
- Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis
- (2010) Tao Xu et al. BMC CANCER
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Carvedilol in glioma treatment alone and with imatinib in vitro
- (2010) Erguven INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
- (2010) Joon H. Uhm et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay
- (2010) Paula Kinsella et al. JOURNAL OF NEURO-ONCOLOGY
- Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
- (2010) Surasak Phuphanich et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
- (2010) Manmeet S. Ahluwalia et al. JOURNAL OF NEURO-ONCOLOGY
- Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin
- (2010) Melarkode S. Ramakrishnan et al. mAbs
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients
- (2010) O. Slaby et al. NEOPLASMA
- mTOR signaling in glioblastoma: lessons learned from bench to bedside
- (2010) D. Akhavan et al. NEURO-ONCOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response
- (2010) C Hartmann et al. ONCOGENE
- Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate
- (2010) Koos E. Hovinga et al. STEM CELLS
- Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
- (2009) B. Neyns et al. ANNALS OF ONCOLOGY
- A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
- (2009) Brian Thiessen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
- (2009) Y. Li et al. CANCER RESEARCH
- Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
- (2009) J. A. Quinn et al. CLINICAL CANCER RESEARCH
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines
- (2009) Efstathia Giannopoulou et al. INVESTIGATIONAL NEW DRUGS
- Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors
- (2009) Fabrizio Griffero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide
- (2009) Martin Glas et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
- (2009) G. L. Gallia et al. MOLECULAR CANCER THERAPEUTICS
- TARGETING THE α 1 SUBUNIT OF THE SODIUM PUMP TO COMBAT GLIOBLASTOMA CELLS
- (2009) Florence Lefranc et al. NEUROSURGERY
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach
- (2008) Cristóbal Belda-Iniesta et al. Clinical & Translational Oncology
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started